Stühler, Viktoria
Alemi, Bilal
Rausch, Steffen
Stenzl, Arnulf
Schwab, Matthias
Schaeffeler, Elke
Bedke, Jens http://orcid.org/0000-0003-2778-3108
Funding for this research was provided by:
Robert Bosch Stiftung
Article History
Received: 17 June 2023
Accepted: 1 December 2023
First Online: 20 January 2024
Declarations
:
: JB reports institutional research grants as local principal investigator from BMS, Ipsen, MSD, Pfizer, Roche, Astellas, AstraZeneca, Eisai, Nektar, Novartis, Seagen; consulting fees from Apogepha, Astellas, AstraZeneca, BMS, Eisai, Ipsen, Janssen, Merck Serono, MSD, Pfizer, Roche, Speakers' bureau fees from Astellas, BMS, Ipsen, Merck Serono, MSD, Pfizer, Roche and Seagen; travel support from Merck and steering committee member for BMS, MSD, Pfizer and Seagen. SR: honoraria for speaker, advisory role: Astellas, Bayer, Pfizer, Merck. AS: consultancies, honoraria, or study participation from Bayer, BMS, Immatics, Novartis, Pfizer, and Roche. The remaining authors declare that they have no competing interests.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University of Tuebingen (565/2020/BO).
: Informed consent was obtained from all subjects involved in the study.